Related Experiment Video
Updated: May 31, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
A probabilistic disease-gene finder for personal genomes
Mark Yandell1, Chad Huff, Hao Hu
1Department of Human Genetics, Eccles Institute of Human Genetics, University of Utah and School of Medicine, Salt Lake City, UT 84112, USA. myandell@genetics.utah.edu
Genome Research
|June 25, 2011
Summary
The Variant Annotation, Analysis & Search Tool (VAAST) accurately identifies disease-causing genetic variants. This powerful tool analyzes personal genomes for both rare and common diseases, even with small sample sizes.
Area of Science:
- Genomics
- Bioinformatics
- Genetic Disease Research
Background:
- Personal genome sequencing generates vast amounts of variant data.
- Existing variant prioritization methods have limitations in accuracy and scope.
- Integrating different analytical approaches can improve variant interpretation.
Purpose of the Study:
- To introduce the Variant Annotation, Analysis & Search Tool (VAAST).
- To present a unified likelihood framework for variant prioritization.
- To demonstrate VAAST's capability in identifying disease-causing genes and variants.
Main Methods:
- VAAST combines amino acid substitution (AAS) and aggregative approaches.
- It utilizes a unified likelihood framework for variant scoring.
- The tool evaluates both coding and noncoding variants, assessing their cumulative impact.
Main Results:
- VAAST achieves greater accuracy in identifying damaged genes and deleterious variants.
- It can identify rare variants linked to rare genetic diseases.
- The tool effectively identifies genes responsible for common, multigenic diseases using small cohorts (n=3) and limited cases (150).
Conclusions:
- VAAST offers a more accurate and user-friendly method for variant analysis.
- Its unified framework enhances the identification of disease-causing genetic variants.
- VAAST demonstrates broad applicability for both rare and common disease research.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...